company coverage

Oxford Biomedica research (LSE:OXB)

Coverage of Oxford Biomedica collects dated research on business quality, return drivers, balance-sheet resilience, valuation scenarios, and what would change the thesis for LSE:OXB.

1 edition linked in this hub.

Coverage

  1. Oxford Biomedica's £40m guidance hole exposes the limits of backlog visibilityOxford Biomedica (LSE:OXB) cut FY26 revenue guidance by £40m at the midpoint. The filings show why backlog is not the same as cash.